AzTrials
AzTrials

Laparoscopic Roux-en-y Gastric BypassNCT03252470

The BlackBox Study

An observational study of Laparoscopic Roux-en-y Gastric Bypass, run by Olympus Corporation of the Americas at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a hypothesis generating pilot study to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox platform, during laparoscopic bariatric surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Laparoscopic Roux-en-y Gastric Bypass
What is being tested?
Laparoscopic Roux-en-y Gastric Bypass Surgery
Type of treatment
Surgery or procedure
How many people
50 participants
Where
1 siteCanada
Study dates
6 Feb 2018to 20 Mar 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who meet all of the inclusion criteria and none of the exclusion criteria will be considered for enrollment in this study.

Who may be able to join

  • ≥ 18 years of age
  • Scheduled to undergo elective, primary roux-en-y gastric bypass surgery
  • BMI of 35 to 54.9
  • Willing and able to provide informed consent

Who cannot join

  • Previous open abdominal surgery
  • Previous open or laparoscopic upper GI surgery
  • Contraindicated for laparoscopic bariatric surgery
  • Unable or unwilling to provide informed consent

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • St. Michael's Hospital, Division of Surgery

    Toronto, Ontario, M5B

Other trials in Canada

About this study

Official title: A Prospective, Post Market, Feasibility Study to Assess the Practical Utility of the OR BlackBox Platform When Used to Compare Surgical Technique During 2D Versus 3D Laparoscopic Bariatric Surgery

This is a hypothesis generating pilot study to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox platform, during laparoscopic bariatric surgery.

Read the detailed description

Data published in 2008 estimated the global number of surgical procedures performed annually as 234 million with a rate of major perioperative complications reported between 3% and 17% in industrialized countries. As a derivative of these figures, it is estimated that approximately 7 to 40 million major complications occur worldwide each year. Studies have shown that between 39.6% and 54.2% of surgical complications occur in the operating room (OR); furthermore, it has been suggested that one third to half of all surgical errors are potentially avoidable. These findings have brought considerable attention to quality improvement in the technically demanding field of laparoscopic surgery wherein the risk of intraoperative error is increased by the sociotechnical complexity of the operative environment. In particular, there has been growing interest in evaluating surgical processes from a human factors point of view, as human factors, such as fatigue and mental workload, have become increasingly recognized as root causes of adverse surgical events and outcomes.

Among the most commonly reported errors in conventional laparoscopic surgery are technical errors associated with impaired depth perception; laparoscopic surgeons rely on two-dimensional (2D) video displays to guide their work in a three-dimensional (3D) space, resulting in the loss of depth perception and spatial orientation, as well as the experience of increased visual and cognitive load. Technical errors can be defined as manual errors of the surgeon (e.g. damage to adjacent structures) and procedural errors due to a lack of surgeon proficiency or experience. These errors are frequently described, especially when evaluating closed malpractice cases. These factors have been extensively examined but still remain controversial. A major limitation of error analyses of closed malpractice cases and root cause analyses of complications is the hindsight bias introduced through the knowledge of patient outcome.

Laparoscopic cameras with 3D display functionality were first developed in the early 1990s. The poor image quality produced by early cameras resulted in pronounced physical side effects, including dizziness, headache, and nausea; however, a significant technological advancement in the field of 3D laparoscopy has dramatically improved the usability of these systems. Despite these improvements and the potential for improved surgical safety, the use of 3D laparoscopic equipment remains limited in modern surgical centers. Outdated and conflicting research findings regarding the effectiveness of these systems and the physical side effects associated with their use may be contributing to slow adoption into clinical practice. Furthermore, investigations assessing the impact of 3D laparoscopy on surgical performance in the clinical setting are notably lacking. Thus, robust comparative evaluations of modern 2D and 3D laparoscopic surgical display systems in clinical settings are required to clearly elucidate the impact of 3D laparoscopy on surgical performance and safety with an aim to establish best practices in laparoscopic surgery.

The restoration of stereoscopic vision in laparoscopic surgery has the potential to mitigate these challenges and, to this end, the introduction of 3D stereoscopic displays in laparoscopic surgery may be beneficial to improving surgical safety. The purpose of this study is to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox Platform, during laparoscopic Roux-en-Y gastric bypass surgery.

Being tested
Laparoscopic Roux-en-y Gastric Bypass Surgery
Keywords
2D laparoscopic surgery, 3D laparascopic surgery, laparoscopic roux-en-y gastric bypass

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic Roux-en-y Gastric Bypass SurgeryProcedure or surgery

    Laparoscopic Roux-en-y Gastric Bypass Surgery

Study groups in NCT03252470
Study groupRoleWhat they receive
2D laparoscopic surgeriesTwo-Dimensional Laparascopic Surgical Video System
Receives: Procedure: Laparoscopic Roux-en-y Gastric Bypass Surgery
3D laparoscopic surgeriesThree-Dimensional Laparascopic Surgical Video System
Receives: Procedure: Laparoscopic Roux-en-y Gastric Bypass Surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantify operative performance and intraoperative errors

    This pilot study will quantify operative performance and intraoperative errors after the introduction of the 2D and 3D technology using the following tools:

    • Generic Error Rating Tool (GERT)
    • Objective Structured Assessment of Technical Skill (OSATS)

    Measured: 12 months

Secondary outcomes (1)
  1. Significant adverse events

    1. Clinically significant adverse events related to the device(s) and/or procedure

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2017
  2. Study start6 Feb 2018
  3. Primary completion11 Mar 2019
  4. Study completion20 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03252470
Sponsor's protocol ID
2015-SE-01
Status last verified
Aug 2019
First submitted
11 Aug 2017
Last updated
14 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Laparoscopic Roux-en-y Gastric Bypass, run by Olympus Corporation of the Americas at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantify operative performance and intraoperative errors (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in